TerminatedNot Applicable

Discharged With Indwelling Chest Tube and Valve

Stopped: Low accrual, end of funding

United States25 participantsStarted 2019-10-07

Plain-language summary

This study is a multicenter, randomized trial for the treatment of subjects discharging from the hospital with a chest tube and valve in place. Subjects will be randomized to receive oral antibiotics and close monitoring, defined as twice weekly telephone calls by a member of the care team, of their chest tube and valve or standard of care, defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥ 18 years of age * Male and Female * Consultation with a thoracic surgeon * Discharge from the hospital with a chest tube and valve in place * Subject is able to understand the study procedures and provide informed consent. Exclusion Criteria: * Pregnancy * Allergy to Keflex and Clindamycin * Special consideration should be taken in enrolling subjects with preexisting conditions that can be exacerbated by antibiotic use but are allowed at the discretion of the treating physician.

What they're measuring

Change in empyema in patient's discharging with an indwelling chest tube and valve.

Timeframe: 30 days post discharge

Trial details

NCT IDNCT03943511

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-20

View on ClinicalTrials.gov More Prolonged Air Leak trials